AR006216A1 - PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES - Google Patents
PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINESInfo
- Publication number
- AR006216A1 AR006216A1 ARP970101003A ARP970101003A AR006216A1 AR 006216 A1 AR006216 A1 AR 006216A1 AR P970101003 A ARP970101003 A AR P970101003A AR P970101003 A ARP970101003 A AR P970101003A AR 006216 A1 AR006216 A1 AR 006216A1
- Authority
- AR
- Argentina
- Prior art keywords
- medicines
- sustained release
- peptide salt
- preparation
- pharmaceutical compositions
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composición farmacéutica, no particulada, de liberación sostenida para la administración parenteral a un paciente, composición que consisteesencialmente en (1) una sal de péptido gelificable, y (2) hasta 30 por ciento por peso de unvehícu lo soluble, monomérico, farmacéuticamente aceptable,compuesta en una forma de sólido cilíndrico, en la cual la composición sólida automática forma un gel tras la interacción con los fluidos corporales delpaciente, y libera el péptido demanera cont inua dentro del paciente en el curso de un período de por lo menos tres días de duración, método para supreparación, uso de una sal de péptido gelificable para preparar medicamentos y medicamentos que los contienen.A sustained release, nonparticulate pharmaceutical composition for parenteral administration to a patient, a composition consisting essentially of (1) a gellable peptide salt, and (2) up to 30 weight percent of a soluble, monomeric, pharmaceutically acceptable vehicle , composed in a cylindrical solid form, in which the automatic solid composition forms a gel upon interaction with the patient's body fluids, and continuously releases the peptide within the patient over the course of a period of at least three days lasting, method for overcoming, use of a gellable peptide salt to prepare drugs and medicines containing them.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP970101003A AR006216A1 (en) | 1997-03-13 | 1997-03-13 | PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP970101003A AR006216A1 (en) | 1997-03-13 | 1997-03-13 | PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES |
Publications (1)
Publication Number | Publication Date |
---|---|
AR006216A1 true AR006216A1 (en) | 1999-08-11 |
Family
ID=51929462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970101003A AR006216A1 (en) | 1997-03-13 | 1997-03-13 | PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR006216A1 (en) |
-
1997
- 1997-03-13 AR ARP970101003A patent/AR006216A1/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9508687A (en) | Sustained release of peptides from pharmaceutical compositions | |
ES2178430T3 (en) | USE OF GELIFICABLE PHARMACEUTICAL COMPOSITIONS IN PARODONTOLOGY. | |
RU94032150A (en) | Medicinal agent exhibiting delayed release of active-acting substance | |
CO4340618A1 (en) | PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE | |
BR9808888A (en) | Dosage forms and method of improving male erectile dysfunction | |
DE3363321D1 (en) | Long-lasting three layered pharmaceutical film preparations | |
CO4750822A1 (en) | TADA PHARMACEUTICAL FORMULATIONS FOR THE ADMINISTRATION IN THE GASTROINTESTINAL TRACT AND PROCESSES TO PREPARE THE SAME | |
CO5261582A1 (en) | VALDECOXIB COMPOSITIONS | |
EA200700049A1 (en) | PREPARATIVE FORMS OF ORAL MEDICINAL FORMS OF MEMANTINE WITH MODIFIED SURVIVAL | |
AR042977A1 (en) | PALONOSETRON LIQUID PHARMACEUTICAL FORMULATIONS | |
CO5261492A1 (en) | DOSAGE FORMS OF CONTROLLED RELEASE THAT INCLUDE ZOLPIDEM OR SALTS OF THE SAME | |
CR7938A (en) | PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMIC ERYTHEMATE LUPUS | |
BRPI0015567B8 (en) | compound, pharmaceutical composition, dosage unit form, use of the pharmaceutical composition and method for preparing a pharmaceutical composition | |
CR7936A (en) | PARENTERAL FORMULATIONS OF A PEPTIDE FOR THE TREATMENT OF SITEMIC ERITEMATOSUS LUPUS | |
AR004391A1 (en) | CONTROLLED RELEASE FORMULATION FOR BASIC PHARMACS SLIMMY SOLUBLE. | |
AR033688A1 (en) | RECONSTITUABLE PARENTERAL COMPOSITION | |
DE60327843D1 (en) | MEDICAMENT FORMULATIONS WITH DELAYED RELEASE WITH A CARRIER PEPTIDE | |
AR036312A1 (en) | PHARMACEUTICAL COMPOSITION | |
BR0013719A (en) | Controlled-release oral dosage, suitable for oral administration | |
WO2005010022A3 (en) | Agonist polypeptide of receptor for zot and zonulin | |
ES2115571T3 (en) | USE OF PENTOSANA POLISULFATE FOR THE RESOLUTION OF SCARS IN CHRONIC PROGRESSIVE VASCULAR DISEASES. | |
CO4970695A1 (en) | PHARMACEUTICAL FORMULATIONS FOR CAPTOTECINE ANALOGS IN GELATIN CAPSULE | |
AR011437A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MIGRANES AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT. | |
AR006216A1 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES FOR SUSTAINED RELEASE, METHOD FOR THE PREPARATION, USE OF A GELABLE PEPTIDE SALT TO PREPARE MEDICINES AND CONTAINING MEDICINES | |
KR900011461A (en) | Therapeutics using trypstatin as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |